The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALECTOR INC | COM | 014442107 | 7,655,073 | 3,808,494 | SH | SOLE | 3,808,494 | 0 | 0 | ||
| AMARIN CORP PLC | SPONSORED ADR | 023111404 | 8,495,733 | 532,982 | SH | SOLE | 532,982 | 0 | 0 | ||
| BEAM THERAPEUTICS INC | COM | 07373V105 | 97,495,981 | 2,840,792 | SH | SOLE | 2,840,792 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 25,226,600 | 2,522,660 | SH | SOLE | 2,522,660 | 0 | 0 | ||
| BURNING ROCK BIOTECH LTD | SPONSORED ADS | 12233L206 | 10,517,747 | 1,238,563 | SH | SOLE | 1,238,563 | 0 | 0 | ||
| CANDEL THERAPEUTICS INC | COM | 137404109 | 996,432 | 96,741 | SH | SOLE | 96,741 | 0 | 0 | ||
| CARIBOU BIOSCIENCES INC | COM | 142038108 | 4,405,812 | 2,503,302 | SH | SOLE | 2,503,302 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 198,065,407 | 5,322,908 | SH | SOLE | 5,322,908 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 141,916,654 | 3,667,097 | SH | SOLE | 3,667,097 | 0 | 0 | ||
| CULLINAN THERAPEUTICS INC | COM | 230031106 | 56,708,344 | 3,114,132 | SH | SOLE | 3,114,132 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | 81,386,599 | 21,703,093 | SH | SOLE | 21,703,093 | 0 | 0 | ||
| ENGENE THERAPEUTICS INC | COM | 29286X101 | 792,089 | 457,855 | SH | SOLE | 457,855 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 8,750,487 | 6,836,318 | SH | SOLE | 6,836,318 | 0 | 0 | ||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 43,656,250 | 1,375,000 | SH | SOLE | 1,375,000 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 10,662,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 86,674,800 | 3,001,205 | SH | SOLE | 3,001,205 | 0 | 0 | ||
| MBX BIOSCIENCES INC | COM | 55287L101 | 51,600,905 | 934,799 | SH | SOLE | 934,799 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 28,984,805 | 1,194,757 | SH | SOLE | 1,194,757 | 0 | 0 | ||
| PARABILIS MEDICINES INC | COM | 698955101 | 6,842,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | 22,884,871 | 661,795 | SH | SOLE | 661,795 | 0 | 0 | ||
| PRELUDE THERAPEUTICS INC | COM | 74065P101 | 12,872,414 | 2,415,087 | SH | SOLE | 2,415,087 | 0 | 0 | ||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 2,913,350 | 1,566,317 | SH | SOLE | 1,566,317 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 61,743,000 | 3,300,000 | SH | SOLE | 3,300,000 | 0 | 0 | ||
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | 17,484,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | 28,968,926 | 872,558 | SH | SOLE | 872,558 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 175,993,964 | 8,050,959 | SH | SOLE | 8,050,959 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 113,620,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| TRAWS PHARMA INC | COM NEW | 68232V884 | 71,175 | 84,400 | SH | SOLE | 84,400 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 89,578,818 | 2,434,207 | SH | SOLE | 2,434,207 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 169,875,334 | 2,922,335 | SH | SOLE | 2,922,335 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 124,012,432 | 2,890,059 | SH | SOLE | 2,890,059 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 118,557,720 | 6,453,877 | SH | SOLE | 6,453,877 | 0 | 0 | ||